Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,180,563 papers from all fields of science
Search
Sign In
Create Free Account
Falmonox
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
teclozan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
[Clinical evaluation of a new amebicide, Falmonox].
J. Matuszak
,
B. Gajda
Polski tygodnik lekarski
1978
Corpus ID: 26291077
1972
1972
Clinical-laboratory trials with teclozan (Falmonox) in mild cases of amoebiasis.
A. Arcilla-Latonio
,
C. A. Arcilla
,
L. Rivera
1972
Corpus ID: 73804240
1970
1970
Appraisal of a new therapeutic course of WIN-13,146 (Teclozan, Falmonox).
J. O. Machado
,
A. L. Pinho
1970
Corpus ID: 68210512
1970
1970
[Evaluation of a new therapeutic schedule of WIN-13,146 (Teclozan-Falmonox)].
Machado Jo
,
D. Al
1970
Corpus ID: 168602046
1970
1970
[Evaluation of a new therapeutic schedule of WIN-13,146 (Teclozan-Falmonox)].
J. O. Machado
,
A. L. D. de Pinho
The Hospital
1970
Corpus ID: 9852561
1969
1969
[Treatment of intestinal amebiasis with Teclozan (Falmonox). Comparative study of therapeutic schemes].
N. A. Cariry
,
M. D. da Silva
The Hospital
1969
Corpus ID: 12090421
1969
1969
Treatment of intestinal amebiasis with Teclozan (Falmonox). Comparative study of therapeutic schemes
Cariry Na
,
D. Ma
1969
Corpus ID: 57656574
1967
1967
Experimental and clinical verification of the amoebicidal activity of Win 13,146 (Teclosan, Falmonox).
J. O. Machado
,
Sérgio Silva
,
F. J. Gomes
1967
Corpus ID: 89525500
1964
1964
[WIN-AM-13146 (FALMONOX) IN INTESTINAL AMEBIASIS].
Pessoa Av
1964
Corpus ID: 77180028
1964
1964
[WIN-AM-13146 (FALMONOX) IN INTESTINAL AMEBIASIS].
A. V. Pessôa
The Hospital
1964
Corpus ID: 31996998
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE